May 15, 2024 - May 17, 2024

Quest Laboratories IPO Review & Recommendations

Dilip Davda has given "May Apply" recommendation to Quest Laboratories IPO.

Quest Laboratories IPO Review Summary from brokers and analysts

Review By	Apply	May Apply	Neutral	Avoid	Not Rated
Count	0	1	0	0	0
%	0.00	100.00	0.00	0.00	0.00

Quest Laboratories IPO Analysis By Brokers/Analysts

Reviewer	Recommendation	Past Reviews
Dilip Davda	May Apply

Quest Laboratories IPO Review by Dilip Davda (May apply)

[Dilip Davda] The company is operating in a highly competitive and fragmented segment. It posted bumper profits from FY22 onwards, that raise eyebrows and concern over its sustainability going forward. Based on FY24 annualized super earnings, the issue appears fully priced. Well-informed/cash surplus investors may park moderate funds for the medium term. Read detail review...

Quest Laboratories IPO Peer Comparison

Quest Laboratories Limited peer comparison with similar listed entities. (As on March 31, 2023)

Company Name	EPS (Basic)	EPS (Diluted)	NAV (per share) (Rs)	P/E (x)	RoNW (%)	P/BV Ratio	Financial statements
Quest Laboratories Limited	4.66	4.66	13.93		33.47
Beta Drugs Limited	19.57	19.57	100.12	66.43	19.55	12.98	Standalone
Alpa Laboratories Ltd.	5.90	5.90	68.69	15.92	8.59	1.37	Standalone
Zenith Drugs Limited	4.29	4.29	14.37	14.69	29.88	4.38	Consolidated

Notes:

The figures for the company are based on Restated Financial Statements for the year ended March 31, 2023 after considering the bonus issue.
The figures for the Peer Group are based on the Standalone Financial Statements filed for the financial year ended March 31, 2023. (Expect for Zenith Drugs Limited Consolidated Financial Statements are considered for period ended March 31, 2023)
P/E Ratio has been computed based on their respective closing market price on May 06, 2024 as divided by the Basic EPS as on March 31, 2023.

Quest Laboratories IPO Review by Members

Quest Laboratories IPO Reviews, analysis and views by popular members. Read Quest Laboratories Limited IPO reviews by retail investors to find recommended ipo to buy.

Post Recommendation Manage Your IPO Reviews

Quest Laboratories IPO Review Summary by Members

Review By	Apply	May Apply	Neutral	Avoid
Count	0	0	0	0
%

Member	Review
No recommendation found. Be the first to post the recommendation.

Post Recommendation Manage Recommendations

Note:

The recommendations or analysis of public issues posted above expresses the views of its author and does not represent the views of Chittorgarh.com or its staff.
We reserve the right to remove any objectionable post without providing a reason.